GLP-1 5 Peptide Strips | StripBox 2a

GLP-1 | 5ct Peptide Strips

$68.00
Regular price  $102.00 Sale price  $68.00
Skip to product information
GLP-1 5 Peptide Strips | StripBox 2a

GLP-1 | 5ct Peptide Strips

$68.00
Regular price  $102.00 Sale price  $68.00
Type
Vials Strips

Bundle & save

Price $68.00
View certificate

For research use only. Not for human consumption. Compassionate curators of fine peptides.

GLP-1 · 2 mg per strip

Mollecule GLP-1 is prepared for metabolic and endocrine research applications where a well-characterized GLP-1 receptor agonist analog is required. Comparable to the active ingredient in Semaglutide. Each batch is manufactured under strict quality controls and independently third-party tested for identity, purity, and consistency. A Certificate of Analysis (COA) is available for every batch.

Pack
5ct Peptide Strips: $68.00

Also available: GLP-1 | Peptide Vials

Strip protocol

Ready-to-use films. No reconstitution.

  1. Keep sealed

    Leave films in the foil pouch at room temperature, away from moisture.

  2. Use dry hands

    Peel one film when needed. It dissolves on liquid contact in 30 to 60 seconds.

  3. Record the lot

    Note the lot number in your lab records and pair it with the matching COA.

Related peptides

Sources & References

Peer-reviewed research

  • NEW ENGLAND JOURNAL OF MEDICINE

    Triple-Hormone-Receptor Agonist GLP-3 (RT) for Obesity - A Phase 2 Trial

    2023 DOI: 10.1056/NEJMoa2301972 Jastreboff AM, et al.

    View Source
  • THE LANCET

    GLP-3 (RT) for People with Type 2 Diabetes - A Phase 2 Trial

    2023 Rosenstock J, et al.

    View Source
  • NATURE MEDICINE

    GLP-3 (RT) for Metabolic Dysfunction-Associated Steatotic Liver Disease

    2024 Sanyal AJ, et al.

    View Source
  • LANCET DIABETES & ENDOCRINOLOGY

    Effects of GLP-3 (RT) on Body Composition

    2025 Coskun T, et al.

    View Source
  • PUBMED CENTRAL

    Triple Agonism Based Therapies for Obesity

    2025

    View Source
  • PUBMED CENTRAL

    GLP-3 (RT) - A Game Changer in Obesity Pharmacotherapy

    2025

    View Source
  • PUBMED CENTRAL

    Efficacy and Safety of GLP-3 (RT) - Systematic Review & Meta-Analysis

    2024

    View Source
  • NATURE CELL DISCOVERY

    Structural Analysis of Incretin Receptor Agonists

    2024

    View Source